Stay updated on LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Sign up to get notified when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.

Latest updates to the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears on the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check60 days agoChange DetectedA new record revision, v3.7.0, was added to the study history, replacing the previous v3.6.6. This reflects an update to the study record's version tracking.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record history adds a new site revision, v3.6.6, replacing the previous v3.6.5; this indicates a routine platform update rather than changes to the study data.SummaryDifference0.1%

- Check95 days agoChange DetectedA new Revision: v3.6.5 entry has been added to the record history. The previous Revision: v3.6.4 entry has been removed.SummaryDifference0.1%

Stay in the know with updates to LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LIB003 vs Evolocumab & Alirocumab in CVD Clinical Trial page.